Locations:

Ophthalmology

22-EYE-3438365 CQD-Fluid volatility in nAMD-Ehlers

March 2, 2023/Ophthalmology/Eye Care & Treatment

Exudative Stability Key to Anti-VEGF Outcome in nAMD

Advanced OCT features may help individualize treatment intervals

22-EYE-3438364 CQD _ OCT-based imaging biomarkers650x450

February 28, 2023/Ophthalmology/Eye Care & Treatment

Unlocking Precision Medicine in RVO: When Anti-VEGF Therapy Isn’t Effective

Intraretinal fluid volumes and other features detectable with OCT may help predict treatment response

23-EYE-3521610 CQD-Time to resolution of DME-Talcott-650×450

February 8, 2023/Diabetes & Endocrinology

Diabetic Macular Edema Can Take 1-2 Years to Resolve in Patients Despite Aggressive Treatment

Greater central subfield thickness and better visual acuity at baseline are associated with longer time to resolution

22-EYE-3391159 CQD-Treating Retinoschisis-hero

December 23, 2022/Ophthalmology/Ophthalmology Research

Long-Term Topical Dorzolamide Improves Visual Acuity in Juvenile X-Linked Retinoschisis

Study followed patients an average of eight years

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

22-EYE-3138272 CQD-Cornea biomechanical changes laser vision corr-Randleman-650×450

November 10, 2022/Ophthalmology/Eye Care & Treatment

‘Second Generation’ Brillouin Microscopy May Better Identify Patients for Refractive Surgery, Corneal Cross-Linking

LASIK causes twice as much corneal weakening as SMILE or PRK, shows study

September 22, 2022/Ophthalmology/News & Insight

Unlocking the Potential of OCT: From Imaging to Biomarker Discovery

Innovative work earns ASRS and Macula Society awards for Justis P. Ehlers, MD

22-EYE-3121760 CQD-Cole Eye AAO Booth Schedule-650×450

September 16, 2022/Ophthalmology/News & Insight

Don’t Miss These Cole Eye Institute Experts at AAO 2022

Speakers and topics for Booth 3254

22-EYE-3066210 CQD-Losartan for corneal fibrosis-Wilson-hero

September 7, 2022/Ophthalmology/Ophthalmology Research

Hypertension Drug Losartan Reverses Scarring and Restores Vision After Cornea Damage

Studies indicate dramatic results when used topically with or without corticosteroids

22-EYE-3141638 CQD-EYP-1901 with vorolanib for maintenance of nAMD

August 23, 2022/Ophthalmology/Ophthalmology Research

DAVIO Trial Results: Vorolanib Injection Reduces Treatment Burden for Patients with nAMD

53% of participants didn’t need anti-VEGF for six months or longer

22-EYE-2953384-CQD-Case study on pat with ocular migraines-str-Bajic

August 19, 2022/Heart, Vascular and Thoracic

Case Study: When Ocular Migraine Symptoms Indicate Impending Stroke

Subtle but important distinctions for ophthalmologists

BackPage 4 of 23Next